The clinical and biological significance of HER2 over-expression in breast ductal carcinoma in situ: a large study from a single institution
The clinical and biological significance of HER2 over-expression in breast ductal carcinoma in situ: a large study from a single institutionThe clinical and biological significance of HER2 over-expression in breast ductal carcinoma in situ: a large study from a single institution, Published online: 08 May 2019; doi:10.1038/s41416-019-0436-3The clinical and biological significance of HER2 over-expression in breast ductal carcinoma in situ: a large study from a single institution
Source: British Journal of Cancer - Category: Cancer & Oncology Authors: Islam M. Miligy Michael S. Toss Kylie L. Gorringe Andrew H. S. Lee Ian O. Ellis Andrew R. Green Emad A. Rakha Source Type: research
More News: Breast Carcinoma | Cancer | Cancer & Oncology | Carcinoma | Carcinoma in Situ | DCIS (Ductal Carcinoma in Situ) | Ductal Carcinoma | HER2 | Study | UK Health